Nonsurgical Procedures Up 230%: MEETH Director

by jfrentzen 8/31/2009 6:17:00 AM

A recent interview with Sherrell J. Aston, MD, FACS caught my eye. Aston is the Surgeon Director and Chairman of the Department of Plastic Surgery at Manhattan Eye, Ear and Throat Hospital (MEETH), where more cosmetic surgery procedures are performed each year than any other institution in the World, according to an online article at Medscape Today. He was asked about trends in aesthetic medicine and, given his credenetials, I doubt that you could get a more insightful commentator on issues of general trends.

For example, he notes new patient volume at MEETH up. The data he references in the article is from the ASPS.

The Price of Looking Good in the Credit Crunch: Here's Aston on how to ride out the recession...


Most business comes from word of mouth. The quality of the care, how patients are treated in the office, and your results affect business and what patients say about you. During all their visits, patients need to feel they are treated with respect, and that they are getting high quality service and great results.

I would suggest expanding your business. It seems to me many plastic surgeons are riding out the storm by doing more reconstructive surgical procedures. Some New York surgeons tell me they had forgotten that they felt good doing reconstructive procedures -- but they had let them go for financial reasons. It'll be interesting to see if, when the economy improves, the surgeons cease performing reconstructive procedures. I suspect many will continue doing reconstructive procedures along with their elective cosmetic surgery. In addition, you can do more fillers and injectables.

Read it all.

Health Care Reform for Breast Reconstruction

by jfrentzen 8/24/2009 9:44:00 AM

I will let this blog entry on health care reform and breast reconstruction speak for itself:

Even though you or your loved one could benefit from advanced breast reconstructive surgery after mastectomy (like the DIEP flap procedure for example), your plastic surgeon might well have to say “no”.

While this may sound extreme to many of you, this would happen if comparative-effectiveness research rules that the benefits of the surgery for the average patient just don't justify its price tag, especially when compared with yesterday's treatments (like tissue expanders for example).

Unfortunately, medical advances and "cutting-edge" procedures do come at a price. Though this does mean certain procedures are more expensive, it has also ensured the United States has stayed at the leading edge of health care in the world, at least until now.

In an enormous break with tradition, such cost considerations based on averages will be factored into medical practice guidelines. These will function as an invisible hand that puts a brake on the more expensive procedures even though they benefit certain patients.

Standardized practice guidelines will be evident everywhere, even embedded into your doctor's government-certified computer: as described in the Obama budget, computer pop-ups will appear to help your doctor make decisions. (And through the same systems, his or her choices can be monitored for consistency with the guidelines.)
 
The author of this piece,  Sharon Lacey, is apparently a Privacy Officer at PRMA of South Texas, The original post can be found in the The Breast Cancer Reconstruction Blog.
 

 

Treating Madarosis Using Eyelash Transplantation

by jfrentzen 8/24/2009 9:03:00 AM
Transform, a UK-based cosmetic surgery group, announced last week the first eyelash transplant. The cost is GBP3500.

Ideal candidates of eyelash transplants are those who suffer from alopecia, trichotillomania (self-inflicted obsessive plucking), or those who lost hair due to radiation or chemotherapy. However, the treatment can also be used for cosmetic purposes to improve the fullness and length of lashes - competing directly with the false lash market.

Read more.

 

Authors

Tags

Powered by BlogEngine.NET 1.3.1.0